However, where competition is limited, the impact would more likely be passed on. Nomura highlighted that the Cipla management comments were “largely aligned with our views . We highlighted that ...
Cipla Limited is an Indian multinational pharmaceutical company that is headquartered in Mumbai, Maharashtra. The company is primarily known for producing generic drugs for various therapeutic uses.
Alvotech acquires Xbrane’s R&D operations and the biosimilar candidate XB003. Xbrane retains some pre-clinical development programs, that it intends to commercialize, and will continue operating as a ...
“The FDA's filing acceptance of Dr. Reddy's proposed denosumab biosimilar marks an important milestone in bringing this biosimilar medication to more patients throughout the U.S.,” said Milan ...
The "Inhalable Biologics Market Size, Share & Trends Analysis Report by Biologics (Peptides & Proteins, Monoclonal Antibodies, RNAi-Based Therapeutics), Application (Diabetes, Cancer), Dosage Form, ...
Cipla has entered a phase of sideways consolidation after a decline of approximately 19.7 per cent from its all-time high, with support at Rs 1,366 and resistance at Rs 1,502. A decisive break and ...
Korean Air rebrands for the first time in 40 years with a simplified new look by Lippincott designed to reach global ...
The company has received final approval from the United States Food and Drug Administration (USFDA) for its New Drug Application submitted for Nilotinib capsules (50 mg, 150 mg, and 200 mg).
Nanoscope Therapeutics Inc., a biotechnology company committed to restoring vision in blind patients in real-world settings ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback